oxazoles has been researched along with Colonic Neoplasms in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (29.17) | 18.7374 |
| 1990's | 3 (12.50) | 18.2507 |
| 2000's | 7 (29.17) | 29.6817 |
| 2010's | 6 (25.00) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, X; Li, C; Wu, W; Zhang, P; Zhang, X; Zhou, S | 1 |
| Cai, WY; Chen, YJ; De, GJ; Hao, DL; Liu, L; Ma, H; Sui, F; Xie, R; Yang, MY; Yi, H; Zang, C; Zhao, QH | 1 |
| Chu, E; Guo, Z; Hopkins, CD; Schmitz, JC; Wei, N; Wipf, P; Wu, S | 1 |
| Bessa, C; Bisio, A; Fernandes, J; Gomes, C; Gomes, S; Gonçalves, J; Inga, A; Monteiro, Â; Pereira, C; Pereira, NA; Queiroz, G; Raimundo, L; Reis, F; Santos, MM; Saraiva, L; Soares, J | 1 |
| Han, H; Stephens, B; Von Hoff, DD; Wang, H | 1 |
| Brown, AM; Cardozo, T; Carson, BB; DasGupta, R; Ekas, LA; Evans, S; Gonsalves, FC; Katz, S; Klein, K; Nagourney, R | 1 |
| Al-Abed, Y; Donia, M; Fagone, P; Maksimovic-Ivanic, D; Mangano, K; McCubrey, JA; Mijatovic, S; Miljkovic, D; Mojic, M; Nicoletti, F; Stankovic, M; Stosic-Grujicic, S; Travali, S; Zocca, MB | 1 |
| Fujii, G; Komiya, M; Mutoh, M; Noma, N; Shimura, M; Takahashi, M; Tanuma, S; Yamamoto, M; Yanaka, A | 1 |
| Hirakawa, K; Nagatsuka, I; Nishino, H; Ohira, M; Seki, S; Shimizu, S; Yamada, N | 1 |
| Doi, K; Fukushima, S; Mitsuhashi, M; Moku, M; Morimura, K; Salim, EI; Shen, J; Wanibuchi, H; Wei, M | 1 |
| Fukushima, S; Hakoi, K; Moku, M; Morimura, K; Salim, EI; Shen, J; Wanibuchi, H; Wei, M | 1 |
| Asakage, M; Hori, N; Kaisaki, S; Kawai, K; Kitayama, J; Nagawa, H; Okaji, Y; Sunami, E; Takahashi, K; Tsuno, NH; Watanabe, T; Yazawa, K | 1 |
| Esumi, H; Ikeda, D; Kawada, M; Kunimoto, S; Masuda, T; Ohba, S; Osono, M | 1 |
| Feng, Y; Hörling, J; Hu, X; Leng, Y; Liu, X; Sydow-Bäckman, M; Yang, YS; Yu, JH; Zhao, XF; Zierath, JR | 1 |
| Cripps, C; Eisenhauer, E; Fields, AL; Maroun, JA; Pater, JL; Stewart, DJ | 1 |
| Bittner, G; Fischer, PH; Pamukcu, R; Willson, JK | 1 |
| Crews, P; Nieto, RM; Rodríguez, J | 1 |
| Hatano, K; Ishihara, S; Kitayama, J; Muto, T; Nagawa, H; Nita, ME; Osada, T; Shibata, Y; Sunami, E; Tomozawa, S; Tsuno, N; Tsuruo, T; Yano, H | 1 |
| Acosta, AL; Rodríguez, AD | 1 |
| Huber, KR; Roberts, J; Rosenfeld, H | 1 |
| Eisenhauer, EA; Fields, AL; Maroun, JA; Walde, PL | 1 |
| Huber, KR; Mayer, EP; Mitchell, DF; Roberts, J | 1 |
| Adolphson, CC; Ajani, JA; Barlogie, B; Bedikian, AY; Bodey, GP; Korinek, J; Stroehlein, JR | 1 |
| Aoki, T; Eble, JN; Glover, JL; Sebolt, JS; Weber, G | 1 |
24 other study(ies) available for oxazoles and Colonic Neoplasms
| Article | Year |
|---|---|
Target-Amplified Drug Delivery of Polymer Micelles Bearing Staudinger Ligation.
Topics: Animals; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Colonic Neoplasms; Doxorubicin; Drug Delivery Systems; Male; Mice, Inbred ICR; Micelles; Nanomedicine; Oxazoles; Polyesters; Polymers; Tissue Distribution | 2019 |
pH-Responsive Artesunate Polymer Prodrugs with Enhanced Ablation Effect on Rodent Xenograft Colon Cancer.
Topics: Animals; Artesunate; Colonic Neoplasms; Drug Delivery Systems; Drug Liberation; Female; Humans; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Mice, Inbred BALB C; Micelles; Oxazoles; Polymers; Prodrugs; Xenograft Model Antitumor Assays | 2020 |
Bis-cyclopropane analog of disorazole C1 is a microtubule-destabilizing agent active in ABCB1-overexpressing human colon cancer cells.
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Blotting, Western; Cell Cycle; Cell Movement; Cell Proliferation; Colonic Neoplasms; Drug Resistance, Multiple; Fluorescent Antibody Technique; Humans; Immunoenzyme Techniques; Macrolides; Microtubules; Oxazoles; Tubulin Modulators; Tumor Cells, Cultured | 2015 |
Reactivation of wild-type and mutant p53 by tryptophanolderived oxazoloisoindolinone SLMP53-1, a novel anticancer small-molecule.
Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Movement; Cell Proliferation; Colonic Neoplasms; High-Throughput Screening Assays; Humans; Immunoenzyme Techniques; Isoindoles; Mice; Mice, Inbred BALB C; Mice, Nude; Mutation; Oxazoles; Piperidones; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Small Molecule Libraries; Tryptophan; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2016 |
Identification and characterization of a novel anticancer agent with selectivity against deleted in pancreatic cancer locus 4 (DPC4)-deficient pancreatic and colon cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; CDC2 Protein Kinase; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colonic Neoplasms; Cyclin B; Cyclin-Dependent Kinases; Dose-Response Relationship, Drug; Flow Cytometry; Genotype; HCT116 Cells; Humans; Inhibitory Concentration 50; Molecular Structure; Oxazoles; Pancreatic Neoplasms; Phosphorylation; Smad4 Protein; Tumor Stem Cell Assay; Xanthones | 2009 |
An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway.
Topics: Animals; Antineoplastic Agents; beta Catenin; Cell Line, Tumor; Colonic Neoplasms; Drosophila melanogaster; Drosophila Proteins; Drug Discovery; Drug Screening Assays, Antitumor; Genes, Reporter; High-Throughput Screening Assays; Humans; Mice; Oxazoles; RNA Interference; Small Molecule Libraries; Transcription, Genetic; Wnt Proteins; Wnt1 Protein; Xenograft Model Antitumor Assays | 2011 |
Therapeutic potential of nitric oxide-modified drugs in colon cancer cells.
Topics: Acetates; Animals; Antineoplastic Agents; Apoptosis; Caspases; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Colonic Neoplasms; Drug Screening Assays, Antitumor; Humans; Male; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Neoplasm Transplantation; Nitric Oxide; Oxazoles; Saquinavir | 2012 |
Novel compound SK-1009 suppresses interleukin-6 expression through modulation of activation of nuclear factor-kappaB pathway.
Topics: Anti-Inflammatory Agents; Cell Line, Tumor; Colonic Neoplasms; Humans; I-kappa B Proteins; Inflammation; Inflammation Mediators; Interleukin-6; Isoindoles; Macrophages; NF-kappa B; Oxazoles; RNA, Messenger; Signal Transduction | 2012 |
Inhibitory effect of a selective cyclooxygenase-2 inhibitor on liver metastasis of colon cancer.
Topics: Animals; Benzenesulfonates; Cell Division; Colonic Neoplasms; Cyclooxygenase 2; Dinoprostone; Dose-Response Relationship, Drug; Endothelial Growth Factors; Enzyme-Linked Immunosorbent Assay; Humans; Isoenzymes; Liver Neoplasms; Lymphokines; Matrix Metalloproteinases; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; Oxazoles; Platelet-Derived Growth Factor; Prostaglandin-Endoperoxide Synthases; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |
Chemopreventive effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on 1, 2-dimethylhydrazine-induced rat colon carcinogenesis.
Topics: 1,2-Dimethylhydrazine; Animals; Benzenesulfonates; Bromodeoxyuridine; Carcinogens; Cell Division; Colon; Colonic Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Progression; Isoenzymes; Male; Oxazoles; Precancerous Conditions; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred F344 | 2003 |
JTE-522, a selective cyclooxygenase-2 inhibitor, inhibits induction but not growth and invasion of 1,2-dimethylhydrazine-induced tubular adenocarcinomas of colon in rats.
Topics: 1,2-Dimethylhydrazine; Adenocarcinoma; Adenoma; Animals; Benzenesulfonates; Biomarkers, Tumor; Carcinogens; Colonic Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Progression; Gene Expression Profiling; Isoenzymes; Male; Oligonucleotide Array Sequence Analysis; Oxazoles; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred F344 | 2005 |
Selective inhibition of cyclooxygenase-2 inhibits colon cancer cell adhesion to extracellular matrix by decreased expression of beta1 integrin.
Topics: Benzenesulfonates; Cell Adhesion; Cell Division; Cell Movement; Colonic Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Down-Regulation; Extracellular Matrix; HT29 Cells; Humans; Integrin beta1; Membrane Proteins; Oxazoles; Prostaglandin-Endoperoxide Synthases; Tumor Cells, Cultured | 2005 |
Antitumor effect of kigamicin D on mouse tumor models.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Colonic Neoplasms; Disease Models, Animal; Doxorubicin; Female; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms; Neovascularization, Pathologic; Oxazoles; Pancreatic Neoplasms; Xenograft Model Antitumor Assays | 2006 |
Effect of a novel non-thiazolidinedione peroxisome proliferator-activated receptor alpha/gamma agonist on glucose uptake.
Topics: 3T3 Cells; Adenocarcinoma; Animals; Biological Transport; Cell Line, Tumor; Colonic Neoplasms; Coumarins; Genes, Reporter; Glucose; Humans; Mice; Muscle, Skeletal; Oxazoles; PPAR alpha; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2007 |
Phase II study of acivicin in colorectal carcinoma: a National Cancer Institute of Canada study.
Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Central Nervous System Diseases; Colonic Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Hematologic Diseases; Humans; Infusions, Parenteral; Isoxazoles; Male; Middle Aged; Oxazoles; Rectal Neoplasms | 1984 |
Enhancement of the sensitivity of human colon cancer cells to growth inhibition by acivicin achieved through inhibition of nucleic acid precursor salvage by dipyridamole.
Topics: Antibiotics, Antineoplastic; Cell Cycle; Cell Line; Cell Survival; Colonic Neoplasms; Dipyridamole; Humans; Isoxazoles; Kinetics; Oxazoles; Ribonucleosides; Ribonucleotides | 1984 |
New structures and bioactivity patterns of bengazole alkaloids from a choristid marine sponge.
Topics: Alkaloids; Animals; Antineoplastic Agents; Colonic Neoplasms; Drug Screening Assays, Antitumor; Humans; Hydrolysis; Melanoma; Oxazoles; Porifera; Tumor Cells, Cultured | 1993 |
Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522.
Topics: Animals; Benzenesulfonates; Cell Division; Colonic Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, Animal; Isoenzymes; Lung Neoplasms; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Oxazoles; Prostaglandin-Endoperoxide Synthases | 1999 |
11-oxoaerothionin: a cytotoxic antitumor bromotyrosine-derived alkaloid from the Caribbean marine sponge Aplysina lacunosa.
Topics: Animals; Antineoplastic Agents; Cell Survival; Colonic Neoplasms; Drug Screening Assays, Antitumor; Humans; Magnetic Resonance Spectroscopy; Molecular Conformation; Molecular Structure; Oxazoles; Porifera; Spiro Compounds | 1992 |
Uptake of glutamine antimetabolites 6-diazo-5-oxo-L-norleucine (DON) and acivicin in sensitive and resistant tumor cell lines.
Topics: Animals; Antibiotics, Antineoplastic; Antimetabolites; Azo Compounds; Biological Transport; Colonic Neoplasms; Diazooxonorleucine; Drug Resistance; Glutamine; Humans; Isoxazoles; Kinetics; Leukemia P388; Lung Neoplasms; Mice; Neoplasms, Experimental; Oxazoles; Tumor Cells, Cultured | 1988 |
Phase II study of acivicin as a 72-hr continuous infusion in patients with untreated colorectal cancer. A National Cancer Institute of Canada Clinical Trials Group Study.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Canada; Colonic Neoplasms; Drug Evaluation; Female; Humans; Infusions, Intravenous; Isoxazoles; Male; Middle Aged; Oxazoles; Rectal Neoplasms | 1987 |
Cell cycle phase perturbations by 6-diazo-5-oxo-L-norleucine and acivicin in normal and neoplastic human cell lines.
Topics: Antimetabolites; Azo Compounds; Cell Cycle; Cell Line; Colonic Neoplasms; Diazooxonorleucine; Drug Evaluation, Preclinical; Glutaminase; Glutamine; Humans; Isoxazoles; Lung Neoplasms; Neoplasms, Experimental; Oxazoles | 1987 |
Phase II trial of acivicin in patients with advanced colorectal carcinoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Colonic Neoplasms; Drug Evaluation; Female; Humans; Isoxazoles; Leukopenia; Male; Middle Aged; Nausea; Neoplasm Metastasis; Oxazoles; Rectal Neoplasms; Vomiting | 1986 |
Inactivation by acivicin of carbamoyl-phosphate synthetase II of human colon carcinoma.
Topics: Antibiotics, Antineoplastic; Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing); Colon; Colonic Neoplasms; Glutamine; Humans; Isoxazoles; Kinetics; Ligases; Oxazoles | 1985 |